248 related articles for article (PubMed ID: 6834852)
1. Comparison of the fate of misonidazole (RO 07-0582) and its metabolite desmethylmisonidazole (RO 05-9963), two hypoxic cell radiosensitizers: penetration properties in tumor bearing rats.
Akel G; Canal P; Mockey E; Vandevoorde E; Laurent F; Soula G
J Pharmacol; 1983; 14(1):67-77. PubMed ID: 6834852
[TBL] [Abstract][Full Text] [Related]
2. [Plasma and tissues distribution of misonidazole (RO 07-0582) in the rat bearing a chimio induced tumor (author's transl)].
Akel G; Canal P; Bugat R; Soula G; Combes PF
J Pharmacol; 1981; 12(4):383-91. PubMed ID: 7321570
[TBL] [Abstract][Full Text] [Related]
3. Nonlinear pharmacokinetics of misonidazole and desmethylmisonidazole in the isolated perfused rat liver.
McManus ME; Monks A; Collins JM; White R; Strong JM
J Pharmacol Exp Ther; 1981 Dec; 219(3):669-74. PubMed ID: 7299690
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of hypoxic cell radiosensitizers: a review.
Workman P
Cancer Clin Trials; 1980; 3(3):237-51. PubMed ID: 7438321
[TBL] [Abstract][Full Text] [Related]
5. The concentration of desmethylmisonidazole in human tumours and in cerebrospinal fluid.
Dische S; Saunders MI; Riley PJ; Hauck J; Bennett MH; Stratford MR; Minchinton AI
Br J Cancer; 1981 Mar; 43(3):344-9. PubMed ID: 7225285
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and metabolic studies of the hypoxic cell radiosensitizer misonidazole.
Flockhart IR; Large P; Troup D; Malcolm SL; Marten TR
Xenobiotica; 1978 Feb; 8(2):97-105. PubMed ID: 415443
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and tumour-penetration properties of the hypoxic cell radiosensitizer desmethylmisonidazole (Ro 05-Ro-9963) in dogs.
White RA; Workman P
Br J Cancer; 1980 Feb; 41(2):268-76. PubMed ID: 7370166
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of the hypoxic radiosensitizers misonidazole and demethylmisonidazole after intraperitoneal administration in humans.
Gianni L; Jenkins JF; Greene RF; Lichter AS; Myers CE; Collins JM
Cancer Res; 1983 Feb; 43(2):913-6. PubMed ID: 6848201
[TBL] [Abstract][Full Text] [Related]
9. Regional measurements of [14C]misonidazole distribution and blood flow in subcutaneous RT-9 experimental tumors.
Blasberg R; Horowitz M; Strong J; Molnar P; Patlak C; Owens E; Fenstermacher J
Cancer Res; 1985 Apr; 45(4):1692-701. PubMed ID: 3978636
[TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics in mice and dogs of nitroimidazole radiosensitizers and chemosensitizers more lipophilic than misonidazole.
White R; Workman P; Owen L
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):473-6. PubMed ID: 7107369
[TBL] [Abstract][Full Text] [Related]
11. Regional [14C]misonidazole distribution in experimental RT-9 brain tumors.
Horowitz M; Blasberg R; Molnar P; Strong J; Kornblith P; Pleasants R; Fenstermacher J
Cancer Res; 1983 Aug; 43(8):3800-7. PubMed ID: 6861144
[TBL] [Abstract][Full Text] [Related]
12. Morphological changes in rat hepatocytes in primary culture induced by Misonidazole, desmethylmisonidazole and Ro 03-8799.
Smith RA
Virchows Arch B Cell Pathol Incl Mol Pathol; 1984; 46(1-2):65-76. PubMed ID: 6147929
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumours.
Brown JM; Yu NY; Workman P
Br J Cancer; 1979 Mar; 39(3):310-20. PubMed ID: 465300
[TBL] [Abstract][Full Text] [Related]
14. Desmethylmisonidazole (Ro 05-9963): clinical pharmacokinetics after multiple oral administration.
Stratford MR; Minchinton AI; Dische S; Saunders MI; Anderson P
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):377-9. PubMed ID: 7107355
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells.
Chapman JD; Baer K; Lee J
Cancer Res; 1983 Apr; 43(4):1523-8. PubMed ID: 6831401
[TBL] [Abstract][Full Text] [Related]
16. The penetration of misonidazole into a mature structural cartilage.
Langler AJ; Bugden RD; Gibson P
Br J Cancer; 1982 Feb; 45(2):282-5. PubMed ID: 7059476
[TBL] [Abstract][Full Text] [Related]
17. Comparison of binding of [3H]misonidazole and [14C]misonidazole in multicell spheroids.
Rasey JS; Grunbaum Z; Krohn K; Nelson N; Chin L
Radiat Res; 1985 Mar; 101(3):473-9. PubMed ID: 3983363
[TBL] [Abstract][Full Text] [Related]
18. Distribution and tumor penetration properties of a radiosensitizer 2-[14C] misonidazole (Ro 07-0582), in mice and rats as studied by whole-body autoradiography.
Akel G; Benard P; Canal P; Soula G
Cancer Chemother Pharmacol; 1986; 17(2):121-6. PubMed ID: 3719893
[TBL] [Abstract][Full Text] [Related]
19. Cellular uptake of misonidazole and analogues with acidic or basic functions.
Dennis MF; Stratford MR; Wardman P; Watts ME
Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Jun; 47(6):629-43. PubMed ID: 3873433
[TBL] [Abstract][Full Text] [Related]
20. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors.
Ono K; Takahashi M; Nishidai T; Dodo Y; Shibamoto Y; Hiraoka M; Yukawa Y; Abe M
Radiat Med; 1984; 2(1):71-5. PubMed ID: 6242712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
